Retrospective Cohort Study
Copyright ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jun 28, 2020; 26(24): 3458-3471
Published online Jun 28, 2020. doi: 10.3748/wjg.v26.i24.3458
Multiphase computed tomography radiomics of pancreatic intraductal papillary mucinous neoplasms to predict malignancy
Stuart L Polk, Jung W Choi, Melissa J McGettigan, Trevor Rose, Abraham Ahmed, Jongphil Kim, Kun Jiang, Yoganand Balagurunathan, Jin Qi, Paola T Farah, Alisha Rathi, Jennifer B Permuth, Daniel Jeong
Stuart L Polk, University of South Florida College of Medicine, Tampa, FL 33612, United States
Jung W Choi, Melissa J McGettigan, Trevor Rose, Abraham Ahmed, Daniel Jeong, Department of Diagnostic and Interventional Radiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, United States
Jongphil Kim, Yoganand Balagurunathan, Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, United States
Kun Jiang, Department of Anatomic Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, United States
Jin Qi, Department of Cancer Physiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, United States
Paola T Farah, Department of Clinical Science, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, United States
Alisha Rathi, Department of Radiology, University of Florida, Gainesville, FL 32610, United States
Jennifer B Permuth, Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, United States
Author contributions: Choi JW, Rose T, Ahmed A, McGettigan M, Balagurunathan Y, Qi J, Farah P, Rathi A and Permuth JB contributed to research design and manuscript editing; Rathi A and Jeong D evaluated radiological imaging; Polk SL and Jeong D wrote the paper; all authors contributed to the manuscript content and revisions prior to submission.
Supported by National Cancer Institute of the National Institutes of Health, No. R37CA229810; and Biostatistics Core Facility at the H. Lee Moffitt Cancer Center and Research Institute, an NCI designated Comprehensive Cancer Center, No. P30-CA076292.
Institutional review board statement: The study was reviewed and approved by University of South Florida Institutional Review Board.
Informed consent statement: Based on the institutional review board approved protocol, patients were not required to give informed consent to this retrospective study because analysis used anonymized data obtained after each patient agreed to treatment by written consent.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Data sharing statement: No additional data are available.
STROBE statement: The authors have read the STROBE statement, and the manuscript was prepared and revised according to STROBE guidelines.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Daniel Jeong, MD, Associate Professor, Department of Diagnostic and Interventional Radiology, H. Lee Moffitt Cancer Center and Research Institute, 12902 USF Magnolia Dr., Tampa, FL 33612, United States. daniel.jeong@moffitt.org
Received: December 30, 2019
Peer-review started: January 8, 2020
First decision: February 28, 2020
Revised: May 9, 2020
Accepted: June 13, 2020
Article in press: June 13, 2020
Published online: June 28, 2020
Abstract
BACKGROUND

Intraductal papillary mucinous neoplasms (IPMNs) are non-invasive pancreatic precursor lesions that can potentially develop into invasive pancreatic ductal adenocarcinoma. Currently, the International Consensus Guidelines (ICG) for IPMNs provides the basis for evaluating suspected IPMNs on computed tomography (CT) imaging. Despite using the ICG, it remains challenging to accurately predict whether IPMNs harbor high grade or invasive disease which would warrant surgical resection. A supplementary quantitative radiological tool, radiomics, may improve diagnostic accuracy of radiological evaluation of IPMNs. We hypothesized that using CT whole lesion radiomics features in conjunction with the ICG could improve the diagnostic accuracy of predicting IPMN histology.

AIM

To evaluate whole lesion CT radiomic analysis of IPMNs for predicting malignant histology compared to International Consensus Guidelines.

METHODS

Fifty-one subjects who had pancreatic surgical resection at our institution with histology demonstrating IPMN and available preoperative CT imaging were included in this retrospective cohort. Whole lesion semi-automated segmentation was performed on each preoperative CT using Healthmyne software (Healthmyne, Madison, WI). Thirty-nine relevant radiomic features were extracted from each lesion on each available contrast phase. Univariate analysis of the 39 radiomics features was performed for each contrast phase and values were compared between malignant and benign IPMN groups using logistic regression. Conventional quantitative and qualitative CT measurements were also compared between groups, via χ2 (categorical) and Mann Whitney U (continuous) variables.

RESULTS

Twenty-nine subjects (15 males, age 71 ± 9 years) with high grade or invasive tumor histology comprised the "malignant" cohort, while 22 subjects (11 males, age 70 ± 7 years) with low grade tumor histology were included in the "benign" cohort. Radiomic analysis showed 18/39 precontrast, 19/39 arterial phase, and 21/39 venous phase features differentiated malignant from benign IPMNs (P < 0.05). Multivariate analysis including only ICG criteria yielded two significant variables: thickened and enhancing cyst wall and enhancing mural nodule < 5 mm with an AUC (95%CI) of 0.817 (0.709-0.926). Multivariable post contrast radiomics achieved an AUC (95%CI) of 0.87 (0.767-0.974) for a model including arterial phase radiomics features and 0.834 (0.716-0.953) for a model including venous phase radiomics features. Combined multivariable model including conventional variables and arterial phase radiomics features achieved an AUC (95%CI) of 0.93 (0.85-1.0) with a 5-fold cross validation AUC of 0.90.

CONCLUSION

Multi-phase CT radiomics evaluation could play a role in improving predictive capability in diagnosing malignancy in IPMNs. Future larger studies may help determine the clinical significance of our findings.

Keywords: Radiomics, Intraductal papillary mucinous neoplasm, Multiphase computed tomography, Pancreas, Oncology, Pancreatic cancer

Core tip: When pancreatic intraductal papillary mucinous neoplasms (IPMNs) are detected on computed tomography (CT) imaging, it is difficult to definitively assess whether they possess benign or malignant pathology. Few studies have investigated the capabilities of CT radiomics in predicting malignant pathology in IPMNs. In this retrospective cohort study on preoperative multiphase post contrast CTs in IPMNs, a combined model using radiomics features and International Consensus Guidelines (ICG) had better diagnostic accuracy in predicting malignant pathology than a model using ICG alone.